Cell and Gene Therapy Manufacturing Services Market Share

Statistics for the 2023 & 2024 Cell and Gene Therapy Manufacturing Services market share, created by Mordor Intelligence™ Industry Reports. Cell and Gene Therapy Manufacturing Services share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Cell and Gene Therapy Manufacturing Services Industry

The cell and gene therapy manufacturing services market is consolidated, competitive, and consists of several major players. A few of the major players are currently dominating the market in terms of market share. Some companies currently dominating the market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories, Lonza, Catalent Inc., Takara Bio Inc., and F. Hoffmann-La Roche Ltd.

Cell and Gene Therapy Manufacturing Services Market Leaders

  1. Charles River Laboratories

  2. Merck KGaA

  3. Thermo Fisher Scientific Inc.

  4. F. Hoffmann-La Roche Ltd

  5. Fujifilm Holdings Corporation

*Disclaimer: Major Players sorted in no particular order

Cell and Gene Therapy Manufacturing Services Market Concentration

Cell and Gene Therapy Manufacturing Services Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)